The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
Abstract
To evaluate the clinical utility of recently developed biochemical markers of bone turnover to monitor the response of osteoporotic patients to antiresorptive therapy, we compared the results of three advanced assays for markers of bone resorption and four of bone formation to high pressure liquid chromatography (HPLC)-fluorometric assays for urinary pyridinoline and deoxypyridinoline. These assays were also used to resolve the uncertainties concerning the rate of bone turnover in late postmenopausal (late-PMP) osteoporotic women. The rate of bone turnover in 85 women (mean +/- SD age, 63 +/- 6 yr) with low bone mass and all more than 5 yr postmenopausal (mean +/- SD yr PMP, 16 +/- 7 yr) was compared to that in 46 premenopausal women (mean +/- SD age, 40 +/- 5 yr) randomly selected from a large cohort and all having a normal spine bone mineral density (BMD). The late-PMP osteoporotic patients were a subset of patients enrolled in a double blind, placebo-controlled, randomized study comparing the effects of several doses of oral alendronate, a potent and specific inhibitor of bone resorption. Periodically during the 2-yr study, the women's spinal BMD and the level of several markers of bone turnover were measured. Serum total and intact osteocalcin, bone-specific alkaline phosphatase, and carboxy-terminal propeptide of type I collagen measured by RIA were used to assess bone formation. To assess bone resorption, we measured the urinary excretion of total pyridinoline (HPLC Pyr) and deoxypyridinoline (HPLC D-Pyr) by HPLC, type I collagen cross-linked N-telopeptide and urinary free PYR (F-Pyr) by enzyme-linked immunosorbent assay, and the serum concentration of type I collagen cross-linked C-telopeptide (ICTP) by RIA. All bone formation markers, except carboxy-terminal propeptide of type I collagen, and all bone resorption markers, except ICTP, were significantly increased above normal (33-171%; P < 0.001) in late-PMP osteoporotic women. The long term within-patient variability assessed over a 15-month period in the placebo group was low and was somewhat lower for serum markers (12.5-17.4%) than for urinary markers (24-29%). Under treatment with alendronate, resorption markers decreased earlier than markers of bone formation, consistent with a direct action of the drug to inhibit osteoclastic bone resorption. With the exception of F-Pyr and ICTP, the levels of bone markers were reduced to the normal premenopausal range, and this steady state was maintained from 6-15 months.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Mathews, C. H., Villanueva, A. R., Kleerekoper, M., Frame, B., & Rao, D. S. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111096 · Cited by 1,545
Long-term fracture prediction by bone mineral assessed at different skeletal sites
Dr. Melton, L. J., Atkinson, E. J., O'Fallon, W. M., Wahner, H. W., & Riggs, B. L. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081010 · Cited by 862
Hanson, D. A., Weis, M. A. E., Bollen, A.-M., Maslan, S. L., Singer, F. R., & Dr. Eyre, D. R. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071119 · Cited by 656
Risteli, J., Elomaa, I., Niemi, S., Novamo, A., & Risteli, L. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.635 · Cited by 622
ERIKSEN, E. F. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-379 · Cited by 601
Which Fractures Are Associated with Low Appendicular Bone Mass in Elderly Women?
Seeley, D. G., Browner, W. S., Nevitt, M. C., Genant, H. K., Scott, J. C., Cummings, S. R., & Study of Osteoporotic Fractures Research Group (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-11-837 · Cited by 558
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen
Melkko, J., Niemi, S., Risteli, L., & Risteli, J. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.7.1328 · Cited by 513
Black, D., Duncan, A., & Robins, S. P. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90274-6 · Cited by 436
Uebelhart, D., Gineyts, E., Chapuy, M.-C., & Delmas, P. D. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90143-n · Cited by 424
Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age
Lips, P., Courpron, P., & Meunier, P. J. (1978) · Calcified Tissue Research · doi:10.1007/bf02013227 · Cited by 411
Parfitt, A. M. (1982) · Metabolic Bone Disease and Related Research · doi:10.1016/0221-8747(82)90002-9 · Cited by 399
Balena, R., Toolan, B. C., Shea, M., Markatos, A., Myers, E. R., Lee, S. C., Opas, E. E., Seedor, J. G., Klein, H., & Frankenfield, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116872 · Cited by 396
Clinical Use of Bone Densitometry
Desforges, J. F., Johnston, C. C., Slemenda, C. W., & Melton, L. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241606 · Cited by 380
Garnero, P. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.4.1046 · Cited by 362
Self-citationUEBELHART, D., SCHLEMMER, A., JOHANSEN, J. S., GINEYTS, E., CHRISTIANSEN, C., & DELMAS, P. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-367 · Cited by 361
Dr. Delmas, P. D., Schlemmer, A., Gineyts, E., Riis, B., & Christiansen, C. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060615 · Cited by 302
EASTELL, R., DELMAS, P. D., HODGSON, S. F., ERIKSEN, E. F., MANN, K. G., & RIGGS, B. L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-741 · Cited by 273
Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women
Štěpán, J. J., Pospíchal, J., Presl, J., & Pacovský, V. (1987) · Bone · doi:10.1016/8756-3282(87)90002-0 · Cited by 264
Immunoassay for urinary pyridinoline: The new marker of bone resorption
Seyedin, S. M., Kung, V. T., Daniloff, Y. N., Hesley, R. P., Gomez, B., Nielsen, L. A., Rosen, H. N., & Zuk, R. F. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080515 · Cited by 242
Smedsrød, B., Melkko, J., Risteli, L., & Risteli, J. (1990) · Biochemical Journal · doi:10.1042/bj2710345 · Cited by 233
Riggs, B. L., Jowsey, J., Goldsmith, R. S., Kelly, P. J., Hoffman, D. L., & Arnaud, C. D. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106967 · Cited by 228
Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
Garnero, P., Grimaux, M., Demiaux, B., Preaudat, C., Seguin, P., & Dr. Delmas, P. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071206 · Cited by 183
Self-citationHarris, S. T. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.6.1399 · Cited by 182
PREVENTION OF POSTMENOPAUSAL BONE LOSS BY TILUDRONATE
REGINSTER, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92927-9 · Cited by 178
Rosen, H. N., Dresner-Pollak, R., Moses, A. C., Rosenblatt, M., Zeind, A. J., Clemens, J. D., & Greenspan, S. L. (1994) · Calcified Tissue International · doi:10.1007/bf00316285 · Cited by 165
Immunoassay of pyridinoline crosslink excretion in normal adults and in paget's disease
Delmas, P. D., Gineyts, É., Bertholin, A., Garnero, P., & Marchand, F. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080516 · Cited by 155
Self-citationHarvey, R., McHardy, K. C., REID, I. W., Paterson, F., Bewsher, P. D., Duncan, A., & Robins, S. P. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1189 · Cited by 150
Analysis of Pyridinoline, a Cross-Linking Compound of Collagen Fibers, in Human Urine1
Fujimoto, D., Suzuki, M., Uchiyama, A., et al. (1983) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a134457 · Cited by 91
Bone turnover in spinal osteoporosis
Pødenphant, J., Johansen, J. S., Thomsen, K., Riis, B. J., Leth, A., & Christiansen, C. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020606 · Cited by 57
Hasling, C., Eriksen, E. F., Melkko, J., Risteli, L., Charles, P., Mosekilde, L., & Risteli, J. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061205 · Cited by 38
Cited by
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy
Odvina, C. V., Zerwekh, J. E., Rao, D. S., Maalouf, N., Gottschalk, F. A., & Pak, C. Y. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0952 · Cited by 1,432
Chesnut, C. H., Skag, A., Christiansen, C., Recker, R., Stakkestad, J. A., Hoiseth, A., Felsenberg, D., Huss, H., Gilbride, J., Schimmer, R. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040325 · Cited by 1,229
Self-citationfor the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1501-1 · Cited by 1,212
Self-citationChesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00490-3 · Cited by 1,122
Metadata
- Authors
- Garnero, P.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-12-01
- Volume
- 79
- Issue
- 6
- Pages
- 1693-1700
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2101280309
- Cited by
- 707
- References
- 30
- FWCI
- 45.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.